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Abstract
Background: Morning light exposure administered as simulated dawn looks a promising method
to treat Seasonal Affective Disorder, but it may moreover help with resetting the inaccurate
organisation of body clock functions relative to sleep occurring in winter among people in general.
Disturbances in sleep patterns are common and may compromise wellbeing even in the short term.
Our hypothesis was that simulated dawn could improve the subjective quality of sleep during
winter.
Methods: A community-based trial with 100 volunteer subjects provided with dawn simulators.
Study period lasted for eight weeks, and subjects used the dawn simulators for two weeks at a time,
each subject acting as his own control (ABAB-design). Main outcome measure was subjective
quality of sleep recorded each morning with Groningen Sleep Quality Scale.
Results: 77 subjects completed the trial. Quality of sleep improved while subjects were using dawn
simulator-devices (p = 0.001). The treatment became beneficial after six days' use of dawn
simulator, but the effect did not last after the use was ceased.
Conclusion: Dawn simulation may help to improve the subjective quality of sleep, but the benefits
are modest. Further research is needed to verify these findings and to elucidate the mechanism by
which dawn simulation acts on the sleep-wake pattern.
Background
Intrinsic biological rhythms allow living organisms to
anticipate and adapt to environmental changes. They are
generated by inherited time-keeping mechanisms and
entrained by signals from the individual's natural habitat
to match the solar day [1] and transitions between diurnal
and nocturnal states [2].
Light is the most important Zeitgeber, or time-giver in
humans. During winter it is thus possible that the biolog-
ical clockwork becomes less stable due to lower light
intensity and shorter photoperiod. We hypothesised that
to a number of people simulated dawn [3,4] would be of
some help during winter in particular. It might keep the
endogenous clock in a desired phase position relative to
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standard clock time, preventing desynchronization, facili-
tating sleep and improving the process of waking up.
Seasonal Affective Disorder (SAD) is a form of recurring
affective disorder, in which a depressive episode usually
begins in autumn/winter and remission follows in spring/
summer (winter-SAD). Bright light (over 2500 lux) is con-
sidered the treatment of choice in winter-SAD, and more
effective than dawn simulation [5]. In a recently pub-
lished controlled trial Avery et al. found that dawn simu-
lation was superior to placebo in alleviating symptoms of
SAD [6]. In an earlier report, a slower light ramp (increas-
ing illuminance over 45 min, peaking at 100 lux) was bet-
ter than rapidly increasing illuminance (4 s, peaking at
100 lux) in improving mood and quality of sleep in sub-
jects with subsyndromal-SAD [7].
Dawn-dusk simulation has been successfully used to treat
disturbed circadian rest-activity cycles in patients with
dementia [8]. We present, to our knowledge, the first
study on the effect of dawn simulation on sleep on a non-
clinical population.
Methods
A random sample, comprising of 1000 subjects aged over
17 years, with 1:1 sex ratio, was drawn from the national
population register of Finland. These one thousand sub-
jects were sent a letter inviting them to take part in a trial
focusing on the effects of dawn simulation on sleep. The
study procedure was briefly described in the invitation let-
ter. No reference to sleeping problems and/or seasonal
changes in mood was made in the recruitment letter. Sub-
jects who were not shift workers and who had not been
hospitalised nor taking medication during the previous
six months were eligible for the study. The first 100 eligi-
ble respondents to the invitation letter were enrolled in
the trial, after giving their written informed consent. This
trial was part of a larger, binational study whose report is
currently under preparation [9].
The study protocol is in concordance with the Helsinki
declaration and its amendments, and it was approved by
the local ethics committee.
The dawn simulators used were 'Light wake-up system'
prototypes (Philips DAP), in which the light source was
placed behind a diffuser. Research assistant provided the
study subjects with the dawn simulator and visited each
subject's bedroom to ensure the correct usage of the appa-
ratus. The assistant checked 1) that the bedrooms could be
darkened (<1 lux), 2) that the dawn simulator could be
placed on a bedside table, or equivalent, on the subject's
side of the bed, at eye level, 3) that the distance to subject's
eyes (approximately 30 cm) and illuminance were same
in all bedrooms. There were no bed partners in the study
subjects. With the dawn simulator the luminance is weak
(<1 lux) initially but intensifies following a linear ramp,
reaching highest level in 30 minutes. After that, the lamp
could be switched off. The trial was preceded by two days
of adaptation during which subjects were instructed to use
the dawn simulator and adjust the maximum level of illu-
minance. They were asked to set it at 200 lx for the first
morning, but allowed to change it to either 100 or 300 lx
for the second. Finally, they were asked to stick to the pre-
ferred level and use it daily throughout the trial. The dawn
simulator was thus to function as their alarm clock on
workdays, and they were also instructed to use it in the
same way, and set for the same time, at weekends. The
trial lasted eight weeks: two weeks of simulated dawn
were followed by two weeks without, and this cycle was
then repeated once. Half of the subjects followed the
opposite design, starting without simulated dawn. Sub-
jects were instructed to contact the research assistant if
they had problems with the dawn simulator. The assistant
collected the study questionnaires and dawn simulators at
the end of each study period.
During the study period all subjects lived in the Helsinki
region or South Finland province (60°–61°N). The study
was performed in two periods (time of sunrise-sunset): 4
October (7:33am–6:43pm) to 29 November (8:53am–
3:24pm), and 10 January (9:16am–3:40pm) to 7 March
(7:02am–6:02pm).
The main outcome measure was quality of sleep, assessed
daily using the 14-item Groningen Sleep Quality Scale
(GSQS; see Appendix 1 for the items on the scale) [10].
GSQS score ranges from 0 to 14, a higher score indicating
lower subjective quality of sleep. The scale was originally
constructed to study sleeping problems of depressed
patients. In a validation study with 80 depressed inpa-
tients, the mean (S.D.) score on the scale was 6.0 (4.2)
and Cronbach's alpha for internal consistency 0.88
[Mulder-Hajonides van der Meulen & van den
Hoofdakker, unpublished data]. The GSQS has previously
been used in a study 27 SAD patients [11], and 70 shift-
workers [12]. In general, if sleep is unrestricted and undis-
turbed, subjects score 0 to 2 points. A higher score (6 to 7)
indicates a disturbed sleep.
At baseline, the subjects filled in the Seasonal Pattern
Assessment Questionnaire (SPAQ; [13]), and the Morn-
ingness-Eveningness Questionnaire (M-EQ; [14]. The
SPAQ measures seasonal changes in mood and behaviour
and includes a 6-item scale yielding the Global Seasonal-
ity Score (GSS), ranging from 0 to 24 points. The SPAQ
criteria for subsyndromal SAD used in this study were
those described by Bartko & Kasper [15]. The M-EQ has 19
items, which are scored from a minimum of 16 points to
a maximum score of 86 points. The scale is divided intoBMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/14
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five types: definitely / moderately morning type, interme-
diate type, and definitely / moderately evening type. In
this study, a tripartite division was used: evening type (M-
EQ score 16 to 31), neither type (42 to 58), or morning
type (59 to 86).
Before the study, subjects were asked about their expecta-
tions on dawn simulation, and how do they think it is
going to make them feel. The question was rated on a
seven-point scale from "really worse" to "really better".
After the study, the participants were asked to rate how
they felt the intervention had affected their general well-
being on a five-point scale from "worse" to "better". Any
possible side effects were also asked after the study from
those who completed the trial.
Data were screened and analysed with the S-Plus 2000
Professional for Windows Release 1 (Mathsoft, Inc.). To
estimate the intervention effect on the GSQS, a linear
mixed-effects model (LME) for longitudinal data was used
[16]. The absolute value of the GSQS was set as the
dependent variable, and treatment effect, treatment × time
interaction, and baseline characteristics as independent
fixed effects. The LME accounts for intra-individual varia-
tion in a repeated measures design by setting the variation
as a random effect and treating each individual as a cluster
in modelling. To test whether the treatment effect lasted
after each intervention, a carry-over indicator was
included in the model.
Results
Of the 100 subjects recruited, 94 entered the study. We
received some sleep quality-data from 91 subjects (97%).
These data are presented in Table 1. Complete data were
received from 77 (82%) subjects, which were included in
the statistical analysis. These subjects were 47 women and
30 men, aged on average 35.3 years (range 18 to 70). Their
mean (S.D.) total GSS was 9.4 (4.3). Twenty-six of them
(33.8%) had a GSS of 12 points or higher. On basis of
SPAQ, 21 subjects (27.3%) were classified as having at
least subsyndromal-SAD. Seven subjects (9.1%) classified
themselves as morning types on the M-EQ and 16
(20.8%) as evening types, the majority (70.1%) being nei-
ther type. The average illuminance from the dawn simula-
tors, chosen by the participants, was 214 lux.
Four subjects dropped out from the study because they
travelled abroad during the study periods. Four subjects
reported that they, or their children, had fallen ill during
the study, and they were unable to complete the question-
naires. Two subjects reported that their dawn simulator
did not work properly. One subject reported that the light
made her nervous. Other subjects (n = 6) who dropped
out from the study did not give any particular reason.
Of those who completed the study, 35% reported the
dawn simulation had made them feel better or a bit better.
9.2% reported they had experienced side effects attributed
to the light.
In the statistical analysis treatment × time interaction was
highly significant (p = 0.001). The quality of sleep
improved constantly (0.19 units per day) during the daily
administration of simulated dawn. It took six days for the
treatment benefit to appear, and after two weeks, the
mean improvement was 1.7 points. The level of light
intensity, age (both as a continuous variable and with a
cut-off point; 40 years or older), sex, season (autumn/win-
ter), seasonality (GSS as a continuous variable and sub-
syndromal SAD; yes / no), morningness-eveningness, and
pre-intervention expectations were accounted for, and did
not influence the outcome. The carry-over indicator was
not significant. Table 2 presents the key results of the
LME-model.
Discussion
Sleep problems are common: in a nation-wide survey in
America, one individual in three reported having occa-
sional difficulty sleeping, and nearly 10% complained of
sleep problems occurring on a regular, nightly basis [17].
Disorders of sleep tend to increase with age [18]. Our
Table 1: Mean (S.D) values on the GSQS after the first and last night of each study period and average score for each two-week period
STUDY PERIOD (PERIODS WITH DAWN SIMULATION MARKED)
I II III IV
FIRST LAST AVERAGE FIRST LAST AVERAGE FIRST LAST AVERAGE FIRST LAST AVERAGE
GROUP 1 
(N = 23)†
4.4 (4.4) 3.4 (5.0) 3.8 (2.9) 3.0 (5.0) 2.4 (4.1) 3.2 (2.0) 2.3 (3.3) 3.3 (5.3) 2.9 (2.0) 3.4 (3.5) 4.8 (5.1) 4.2 (3.3)
GROUP 2 
(N = 23)†
4.7 (3.6) 2.7 (3.1) 3.7 (1.8) 2.5 (3.9) 2.1 (2.3) 3.0 (1.7) 3.2 (3.1) 1.7 (3.4) 2.7 (1.4) 5.7 (3.7) 1.1 (1.8) 2.9 (1.0)
GROUP 3 
(N = 20)‡
5.7 (4.8) 4.8 (5.2) 3.9 (2.8) 2.6 (4.2) 3.2 (4.8) 2.8 (1.8) 3.4 (3.8) 2.6 (4.2) 2.4 (1.6) 4.7 (4.4) 2.4 (4.5) 2.7 (2.1)
GROUP 4 
(N = 25)‡
5.4 (4.4) 5.0 (4.5) 5.0 (3.4) 2.0 (3.2) 3.8 (4.4) 3.0 (1.8) 4.0 (4.0) 2.6 (3.6) 3.5 (1.9) 3.5 (3.7) 1.9 (4.6) 2.8 (1.4)
† AUTUMN GROUP (OCTOBER TO NOVEMBER) ‡ WINTER GROUP (JANUARY TO MARCH)BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/14
Page 4 of 5
(page number not for citation purposes)
results suggest that simulated dawn improves subjective
quality of sleep during the dark months in autumn and
winter. It appears effective in relatively healthy males and
females regardless of age.
Simulated dawn has been shown to prevent the phase
delay naturally occurring in the human circadian pace-
maker [19]. In addition, even one simulated dawn is suf-
ficient to phase advance the timing of the onset of
melatonin secretion [20]. This phase advance might be
one mechanism explaining the observed benefits on
sleep. However, we didn't measure melatonin levels in
this field study, so the hypothesis can't be confirmed.
Also, contrary to the phase delay hypothesis, subjects with
possible (subsyndromal)-SAD and those regarding them-
selves as "night owls" on the M-EQ, did not benefit from
the intervention more than others. Timing of the light
stimuli relative to circadian phase was not controlled in
this study; the subjects were asked to keep their sleep-
wake rhythms constant, but they were free to choose the
wake-up time. This naturally limits the interpretation of
the results.
Another shortcoming of the study is admittedly its design:
we did not have a placebo condition, and the subjects
were acting as their controls. Lack of creditable placebo is
common in trials with bright light [21]. Also, selection
must have occurred in the invitation phase: it is more
probable that subjects regarding dawn simulation favour-
ably participated. We did, however, measure the pre-inter-
vention expectations, and they were not found to
influence the results.
The Groningen Sleep Quality Scale seems a promising and
reliable method of measuring sleep quality even in the
general population. In future it should, however, be vali-
dated against more established questionnaires, e.g. The
Pittsburgh Sleep Quality Index [22].
Conclusion
Simulated dawn appears to be a safe, relatively well-toler-
ated, and possibly effective means of alleviating sleep dis-
turbances related to the shorter photoperiod during
winter. However, the improvement on quality of sleep
was modest, and we could not identify a specific sub-
group who would especially benefit from this
intervention.
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Appendix – The Groningen Sleep Quality Scale
1. I had a deep sleep last night
2. I feel that I slept poorly last night
3. It took me more than half an hour to fall asleep last
night
4. I woke up several times last night
5. I felt tired after waking up this morning
6. I feel that I didn't get enough sleep last night
7. I got up in the middle of the night
8. I felt rested after waking up this morning
9. I feel that I only had a couple of hours' sleep last night
Table 2: Effect of simulated dawn and baseline characteristics on the quality of sleep scale.
Value 95% CI p-value
Treatment effect 0.94 -0.14 to 2.07 0.1
Treatment × time effect1 -0.19 -0.30 to -0.07 0.001
Pre-intervention expectations -0.58 -1.50 to 0.35 0.2
Age2 0.005 -0.02 to 0.03 0.7
Seasonality3 0.28 -0.03 to 0.60 0.08
M-EQ – morningness -0.28 -0.87 to 0.31 0.4
M-EQ – eveningness 0.03 -0.25 to 0.31 0.8
Time of year (autumn/winter) -0.07 -0.34 to 0.20 0.6
1 The effect of treatment and time interaction on a linear scale 2 As a continuous variable 3 Sub-syndromal SAD, yes vs. noPublish with BioMed Central    and   every 
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10. I feel that I slept well last night
11. I didn't sleep a wink last night
12. I didn't have trouble falling asleep last night
13. After I woke up last night, I had trouble falling asleep
again
14. I tossed and turned all night last night
15. I didn't get more than 5 hours' sleep last night
All items are scored true / false
The first question does not count for the total score
One point if answer is 'true': questions 2, 3, 4, 5, 6, 7, 9,
11, 13, 14, 15
One point if answer is 'false': questions 8, 10, 12
Maximum score 14 points, indicating poor sleep the night
before
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